ADRs End Mostly Lower, Teva Pharmaceutical and Honda Trade Actively

By Kathryn Hardison

International stocks trading in New York closed mostly lower on Monday.

The S&P/BNY Mellon index of American depositary receipts edged 0.3% lower to 136.60. The European index was flat at 126.81, the Asian index fell 0.9% to 166.53, the Latin American index rose 0.5% to 192.17 and the emerging markets index decreased 0.8% to 285.79.

Teva Pharmaceutical Industries Ltd. and Honda Motor Co. Ltd. were among the companies with ADRs that traded actively.

ADRs of Teva Pharmaceutical fell 2% after it said the European Commission granted a marketing authorization for Ranivisio, a biosimilar of the ophthalmology treatment Lucentis across all five indications in adults for which Lucentis is authorized. Ranivisio will be the first ophthalmology biosimilar of Lucentis to be commercialized in Europe, the company said.

ADRs of Honda Motor Co. increased 1.8% on the news that Honda and LG Energy Solution Ltd. are planning to build a multibillion-dollar electric-vehicle battery plant in Ohio, The Wall Street Journal reported, citing people familiar with the matter.

ADRs of Novartis AG fell 0.5% after it said the European Commission approved its Scemblix treatment for adults with chronic myeloid leukemia.

Write to Kathryn Hardison at [e-mail]

(END) Dow Jones Newswires

08-29-22 1729ET